Functionality study of santalin as tyrosinase inhibitor: A potential depigmentation agent

Area of Science:

• Biochemistry
• Dermatology
• Natural Product Chemistry

Background:

• Hyperpigmentation disorders stem from excessive melanin production, impacting aesthetics.
• Current synthetic depigmenting agents carry risks of cytotoxicity and mutagenicity.
• There is a critical need for safe, non-toxic natural tyrosinase inhibitors.

Purpose of the Study:

• To investigate the potential of santalin, a Pterocarpus santalinus constituent, as a natural tyrosinase inhibitor.
• To elucidate the mechanism by which santalin affects melanin synthesis.
• To evaluate the safety and efficacy of santalin for cosmetic applications in treating hyperpigmentation.

Main Methods:

• In vitro assays to assess tyrosinase inhibition kinetics and santalin's interaction with tyrosinase.
• Circular dichroism spectroscopy to analyze structural changes in tyrosinase upon santalin binding.
• Molecular docking simulations to predict santalin's binding site within tyrosinase.
• In vitro studies on B16F0 melanoma cells to evaluate melanogenesis inhibition and cytotoxicity.

Main Results:

• Santalin demonstrated dose-dependent inhibition of tyrosinase activity with a mixed-type, reversible mechanism.
• Santalin binds to tyrosinase, inducing structural changes and interacting with the catalytic core via hydrogen and hydrophobic bonds.
• In vitro, santalin inhibited melanogenesis by down-regulating MITF, tyrosinase, TRP-1, and TRP-2.
• Santalin exhibited no cytotoxic effects on B16F0 melanoma cells.

Conclusions:

• Santalin possesses significant anti-tyrosinase and anti-melanogenesis activities.
• The mechanism involves direct interaction with tyrosinase and down-regulation of key melanin synthesis proteins.
• Santalin represents a promising, safe, and natural alternative for cosmetic treatment of hyperpigmentation disorders.